Inventor · disambiguated record
Wen-Hwa Lee
Also filed as: LEE WEN-HWA
21 granted patents·4 pending applications·189 citations·filing 1987–2022
94Inventor score
Top patents by PatentIndex Score
25 records- 0185US5532220AGenetic mechanisms of tumor suppressionUNIV CALIFORNIA·Filed 1994·Granted Jul 2, 1996·74 cites·6 claims
- 0283US10793628B2Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapyACADEMIA SINICA·Filed 2015·Granted Oct 6, 2020·3 cites·14 claims
- 0377US9422275B2Small molecule modifiers of the HEC1-NEK2 interaction in G2/MUNIV CALIFORNIA·Filed 2014·Granted Aug 23, 2016·2 cites·12 claims
- 0476US10421753B2RAD51 inhibitors and uses thereofUNIV CALIFORNIA·Filed 2016·Granted Sep 24, 2019·2 cites·21 claims
- 0575US5710022ANuclear mitotic phosphoproteinUNIV TEXAS·Filed 1994·Granted Jan 20, 1998·39 cites·8 claims
- 0674US9012455B2Pharmaceutical compositions containing an indoyl isoquinoline containing compound and uses thereofLEE WEN-HWA·Filed 2007·Granted Apr 21, 2015·2 cites·2 claims
- 0770US8293764B2Compositions and methods for disruption of BRCA2-Rad51 interactionLEE WEN-HWA·Filed 2005·Granted Oct 23, 2012·2 cites·8 claims
- 0865US4942123AppRB110 -phosphoprotein the retinoblastoma susceptibility gene productUNIV CALIFORNIA·Filed 1987·Granted Jul 17, 1990·19 cites·17 claims
- 0959US10730864B2RAD51 inhibitors and uses thereofUNIV CALIFORNIA·Filed 2019·Granted Aug 4, 2020·0 cites·47 claims
- 1058US2024299567A1Recombinant polypeptides, conjugates comprising the same, and uses thereofSHIH MING CHE·Filed 2022·Application pending·0 cites
- 1156US9670197B2Small molecule modifiers of the Hec1-Nek2 interaction in G2/MUNIV CALIFORNIA·Filed 2016·Granted Jun 6, 2017·0 cites·14 claims
- 1256US5851991ATherapeutic use of the retinoblastoma susceptibility gene productUNIV CALIFORNIA·Filed 1994·Granted Dec 22, 1998·16 cites·24 claims
- 1351US2024124528A1Antagonist of interleukin-17b receptor (il-17rb) and use thereofACADEMIA SINICA·Filed 2021·Application pending·0 cites
- 1445US7060688B2Products and methods for controlling the suppression of the neoplastic phenotypeUNIV CALIFORNIA·Filed 2001·Granted Jun 13, 2006·0 cites·8 claims
- 1545US2013052157A1Use of il-17e for cancer treatmentFURUTA SAORI·Filed 2009·Application pending·0 cites
- 1644US2015272774A1Massage toolLEE WEN-HWA·Filed 2014·Application pending·0 cites
- 1743US5011773AHuman esterase D, its uses and a process of purificationUNIV CALIFORNIA·Filed 1987·Granted Apr 30, 1991·8 cites·11 claims
- 1841US5821070AAntibodies reactive with retinoblastoma binding proteins and methods of using sameUNIV TEXAS·Filed 1993·Granted Oct 13, 1998·4 cites·16 claims
- 1939US7105156B1Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cellsCANJI INC·Filed 1995·Granted Sep 12, 2006·3 cites·11 claims
- 2037US8252520B2Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseasesLEE WEN-HWA·Filed 2003·Granted Aug 28, 2012·0 cites·9 claims
- 2137US5998134ARetinoblastoma gene-cancer suppressor and regulatorUNIV CALIFORNIA·Filed 1995·Granted Dec 7, 1999·4 cites·4 claims
- 2235US5858771AProducts and methods for controlling the suppression of the neoplastic phenotypeUNIV CALIFORNIA·Filed 1994·Granted Jan 12, 1999·6 cites·6 claims
- 2331US6051396AMethod for producing retinoblastoma gene protein productsUNIV CALIFORNIA·Filed 1993·Granted Apr 18, 2000·3 cites·7 claims
- 2430US5578701AppRB110 - nuclear phosphoprotein - the retinoblastoma susceptibility gene productUNIV CALIFORNIA·Filed 1994·Granted Nov 26, 1996·2 cites·4 claims
- 2521US6133424AppRB110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene productUNIV CALIFORNIA·Filed 1995·Granted Oct 17, 2000·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →